Cargando…

New translocation in acute myeloid leukemia M4 eos

The most common childhood malignancy is acute leukemia. Approximately 15- 20% of it, is Acute myeloid leukemia (AML). The general symptoms of this malignancy include fatigue, weakness, fever, paleness and bleeding disorders. There are two methods of classifying for AML: The French-American-British (...

Descripción completa

Detalles Bibliográficos
Autores principales: Bahoush, Gholamreza, Vafapour, Maryam, Kariminejad, Roxana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7296338/
https://www.ncbi.nlm.nih.gov/pubmed/32566479
http://dx.doi.org/10.1016/j.lrr.2020.100209
_version_ 1783546829874397184
author Bahoush, Gholamreza
Vafapour, Maryam
Kariminejad, Roxana
author_facet Bahoush, Gholamreza
Vafapour, Maryam
Kariminejad, Roxana
author_sort Bahoush, Gholamreza
collection PubMed
description The most common childhood malignancy is acute leukemia. Approximately 15- 20% of it, is Acute myeloid leukemia (AML). The general symptoms of this malignancy include fatigue, weakness, fever, paleness and bleeding disorders. There are two methods of classifying for AML: The French-American-British (FAB) and the World Health Organization (WHO) classification.The M4 eos subtype, also called myelomonocytic leukemia, is one subtype of AML with eosinophilia. The most common cytogenetic variations in this leukemia include inv (16) (p13q22) or the variant t (16; 16) (p13; q22). In this report, we present the first AML-M4 eos case with a new translocation that has not yet been reported.
format Online
Article
Text
id pubmed-7296338
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-72963382020-06-18 New translocation in acute myeloid leukemia M4 eos Bahoush, Gholamreza Vafapour, Maryam Kariminejad, Roxana Leuk Res Rep Article The most common childhood malignancy is acute leukemia. Approximately 15- 20% of it, is Acute myeloid leukemia (AML). The general symptoms of this malignancy include fatigue, weakness, fever, paleness and bleeding disorders. There are two methods of classifying for AML: The French-American-British (FAB) and the World Health Organization (WHO) classification.The M4 eos subtype, also called myelomonocytic leukemia, is one subtype of AML with eosinophilia. The most common cytogenetic variations in this leukemia include inv (16) (p13q22) or the variant t (16; 16) (p13; q22). In this report, we present the first AML-M4 eos case with a new translocation that has not yet been reported. Elsevier 2020-06-08 /pmc/articles/PMC7296338/ /pubmed/32566479 http://dx.doi.org/10.1016/j.lrr.2020.100209 Text en © 2020 Published by Elsevier Ltd. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Bahoush, Gholamreza
Vafapour, Maryam
Kariminejad, Roxana
New translocation in acute myeloid leukemia M4 eos
title New translocation in acute myeloid leukemia M4 eos
title_full New translocation in acute myeloid leukemia M4 eos
title_fullStr New translocation in acute myeloid leukemia M4 eos
title_full_unstemmed New translocation in acute myeloid leukemia M4 eos
title_short New translocation in acute myeloid leukemia M4 eos
title_sort new translocation in acute myeloid leukemia m4 eos
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7296338/
https://www.ncbi.nlm.nih.gov/pubmed/32566479
http://dx.doi.org/10.1016/j.lrr.2020.100209
work_keys_str_mv AT bahoushgholamreza newtranslocationinacutemyeloidleukemiam4eos
AT vafapourmaryam newtranslocationinacutemyeloidleukemiam4eos
AT kariminejadroxana newtranslocationinacutemyeloidleukemiam4eos